Description
Bevnexxa 400mg Injection is a vital medication used in the treatment of various oncological conditions. Its active ingredient, Bevacizumab, is a recombinant humanized monoclonal antibody that targets Vascular Endothelial Growth Factor (VEGF). By inhibiting VEGF, Bevnexxa effectively blocks the formation of new blood vessels that tumors need to grow and spread. This anti-angiogenic mechanism starves the tumor of oxygen and nutrients, thereby slowing down or halting its progression. Bevnexxa 400mg Injection is indicated for the treatment of metastatic colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, metastatic renal cell carcinoma, and persistent, recurrent, or metastatic cervical cancer. The dosage and administration should strictly follow the physician’s prescription, as it is typically administered intravenously. Common side effects may include hypertension, proteinuria, fatigue, and gastrointestinal issues. Patients should be monitored for potential serious adverse events such as bleeding, wound healing complications, and gastrointestinal perforation. Store Bevnexxa 400mg Injection as per the manufacturer’s instructions, typically refrigerated.
